Ionic conductivity acceptance and in-line QC method for solid-state electrolyte manufacturing

The solid-state battery industry faces a persistent, underappreciated manufacturing challenge: even when cell engineers select well-characterized, chemically public-domain electrolytes — garnet-structure Li7La3Zr2O12, argyrodite Li6PS5Cl, thio-LISICON variants such as Li10GeP2S12, and sodium analogues like Na3PS4 — the ionic conductivity of received lots varies substantially depending on synthesis route, particle size distribution, residual moisture, and cold-pressing conditions. A pellet that nominally matches the published benchmark conductivity of ~2.05 mS/cm for Li6PS5Cl or ~2.77 mS/cm for LGPS can in practice arrive well below specification, silently degrading cell performance and inflating internal-resistance budgets without triggering a composition-based rejection criterion. The patent art has not historically framed this as a claimable process discipline; most QC claims in the electrolyte space attach to composition or to formation protocols rather than to a measurement-gated acceptance and lot-disposition step tied to a pre-registered conductivity threshold. This asset occupies a specific and deliberately bounded role within the solid-state battery electrolytes and interfaces portfolio: it converts the manufacturing team's unavoidable reliance on public-domain electrolytes into a process and quality-control position. Because no new compound is claimed — and none could be — the value is procedural rather than compositional. The method defines how incoming lots of any solid electrolyte are tested, scored against a pre-registered room-temperature AC-impedance threshold, and either accepted into the assembly line for Family A-L stacks or rejected before they reach the cell stack. That integration step — tying a measured conductivity criterion to manufacturing disposition decisions for a defined stack family — is where the claimable novelty resides, to the extent such novelty exists. Buyers should understand this asset frankly: it is a defensive and supporting filing, not a flagship composition patent, and its value lies in closing a process whitespace around public-domain materials rather than in staking a claim on any particular compound.

This is a process and quality-control method, not a material claim. There is no novel composition, no crystal structure, and no band-gap or transport property being staked. The technical core is an acceptance-and-disposition workflow built around room-temperature AC-impedance spectroscopy on cold-pressed pellets with ion-blocking (electron-only) electrodes — a well-understood measurement geometry that isolates bulk ionic conductivity from electronic leakage. The pre-registered threshold is the key technical element: a specific conductivity value in S/cm, set before lot arrival, against which measured sigma is compared. Exemplary benchmarks drawn from the open literature include approximately 2.05 mS/cm for Li6PS5Cl (argyrodite) and approximately 2.77 mS/cm for Li10GeP2S12 (LGPS-family), both of which are established public-domain compounds with decades of published conductivity data. The method does not attempt to claim these compounds or their conductivities; it claims the act of measuring them against a threshold and using that measurement outcome to gate downstream manufacturing. The integration into stack manufacturing is the second technical element of substance. By tying the conductivity acceptance decision directly to the assembly workflow for a defined family of all-solid-state battery stacks, the method creates a traceable process chain from incoming material characterization to finished cell. This is meaningful from a manufacturing-process standpoint because cell-to-cell variation in interfacial resistance — a major yield and performance driver in ASSB production — can propagate from electrolyte-lot variability if no upstream sigma gate exists. The dependent claim strategy adds further technical grounding by reciting a specific correlation between measured sigma and change in interfacial resistance (dR_int), which if validated would give the threshold criterion a direct cell-performance rationale rather than an arbitrary specification floor. Because this is a method patent rather than a materials patent, the computational validation infrastructure used elsewhere in the portfolio — machine-learning interatomic potentials, phonon stability screening, DFT migration barriers — is not applicable here. There are no crystal structures to relax, no phonon dispersions to compute, and no nudged-elastic-band calculations to run for migration barriers. The technical rigor instead comes from the measurement protocol itself: the use of AC impedance with ion-blocking contacts is the correct and accepted technique for extracting bulk conductivity in a pressed-pellet geometry, and specifying cold-pressing conditions and electrode geometry removes ambiguity in the measurement. The claim's technical defensibility rests on that specificity, not on computational proof.

The addressable market for this particular asset is intentionally constrained by its design. It carries no composition claim, so it cannot generate royalties on electrolyte materials sales. Its commercial value is procedural and defensive: a manufacturer who adopts this specific measurement-gated acceptance workflow, integrated into a named stack family's production line, would practice the claim. The practical buyers are cell manufacturers building ASSB stacks, particularly those who source solid electrolyte powder from third-party suppliers and need a contractual and process basis for lot rejection. Incoming-inspection discipline of this kind has real operational value — it prevents low-conductivity lots from reaching expensive stack assembly — but that value is largely captured as cost avoidance rather than as a licensable royalty stream from electrolyte sales. Royalty or licensing logic for a process/QC method of this nature typically attaches to manufacturing agreements rather than to per-unit material royalties. A cell manufacturer might license or cross-license the method as part of a broader technology-transfer package, or a equipment supplier offering in-line impedance measurement systems for battery production could find value in bundling the protocol. However, the standalone commercial value is limited. The true function of this asset within the solid-state battery electrolytes and interfaces portfolio is to occupy process whitespace: it ensures that even when the portfolio's novel compositions (the flagship garnet, argyrodite, and thio-LISICON variants claimed elsewhere) are not the electrolyte in a given customer's stack, the portfolio still holds a procedural position over how that customer qualifies and accepts whatever public-domain electrolyte they do use. That defensive coverage role, rather than direct monetization, is the correct frame for assessing this asset's commercial contribution.

converts unavoidable reliance on public-domain electrolytes into a process/QC asset claiming the manufacturing discipline

claims the measurement-keyed acceptance/disposition method + integration into Family A-L stack manufacture; no composition claimed

The most natural strategic acquirer or licensee for this asset is a cell manufacturer who is building ASSB production capacity using public-domain electrolytes and who wants a defensible process IP position around their manufacturing discipline. Tier-1 automotive cell suppliers — particularly those investing in sulfide-electrolyte ASSB lines, where lot-to-lot conductivity variation is a known production challenge — would derive the most operational and IP value from holding this method. A second category of interested party is equipment suppliers who sell in-line impedance measurement systems for battery manufacturing: bundling a licensed process protocol with measurement hardware creates a differentiated offering and a justification for premium pricing. Within the context of a portfolio acquisition or licensing transaction, this asset is best understood as a supporting piece that strengthens the buyer's overall process IP position alongside the compositional claims in the solid-state battery electrolytes and interfaces portfolio. It is not a standalone licensing asset with independent royalty-generation potential. A buyer acquiring the broader portfolio should treat this asset as defensive coverage that prevents a third party from filing a blocking process claim over incoming-acceptance methodology while the buyer relies on the portfolio's novel compositions in production. Its value in that context is real but bounded — it closes a gap rather than opens a market.

The primary risk for this asset is eligibility under the abstract-idea doctrine in U.S. patent law. A method claim that recites measuring a physical property and comparing it to a threshold walks close to the line between a patent-eligible process and an ineligible abstract idea. The claim's grounding in physical measurement steps and its integration into a specific manufacturing context — stack assembly for a defined all-solid-state battery family — are the elements that push it toward eligibility, and prosecution strategy should emphasize those elements at every stage. If the claim is drafted or narrowed in a way that divorces the measurement from the manufacturing integration, eligibility risk rises sharply. The second material risk is obviousness. In-coming impedance-based quality control of solid electrolytes is not a surprising idea; any process engineer familiar with the field would recognize it as good practice. The claim must be differentiated from the general concept by the pre-registration requirement, the ion-blocking electrode geometry specification, and the explicit integration into a named stack-assembly workflow. The validation roadmap to de-risk this asset is straightforward: generate experimental data establishing the sigma-to-dR_int correlation for at least one electrolyte family and at least one stack configuration, nail down a specific threshold value with measurement conditions, and document the pre-registration procedure. Those experiments, likely achievable within a single manufacturing-scale experimental campaign, would convert the current open prosecution gates into closed ones and substantially strengthen both the claim and its litigation posture.